# Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

> **NCT00005798** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 209 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cyclophosphamide
- **DRUG:** Thiotepa

## Key facts

- **NCT ID:** NCT00005798
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-07
- **Primary completion:** 2001-08
- **Final completion:** 2007-07
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2012-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005798, "Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00005798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
